Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

SEC filing history

Showing 801-825 of 1,000 matching filings.

Per page
25
Current page
33
4

FORM 4 SUBMISSION

Filing date
18 Dec 2012
Reporting date
14 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
17 Dec 2012
Reporting date
17 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-50549

CT ORDER filing

Filing date
20 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
08 Nov 2012
Reporting date
08 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
03 Oct 2012
Reporting date
28 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Oct 2012
Reporting date
01 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Oct 2012
Reporting date
01 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Oct 2012
Reporting date
01 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Oct 2012
Reporting date
01 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Oct 2012
Reporting date
01 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Aug 2012
Reporting date
22 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Aug 2012
Reporting date
27 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
08 Aug 2012
Reporting date
08 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jul 2012
Reporting date
12 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jul 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jul 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jul 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jul 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jul 2012
Reporting date
04 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jul 2012
Reporting date
01 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jul 2012
Reporting date
01 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jul 2012
Reporting date
01 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jul 2012
Reporting date
01 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .